Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Alta Partners
AddedFeb 13, 2024
UpdatedJun 28, 2026
Alta Partners

Alta Partners

Operating

Alta Partners: A San Francisco-based venture capital firm specializing in biotech and life sciences.

Location
Jackson, MS, US
Founded
1996
Firm
Compare
Portfolio
Employees
Website

Alta Partners is a San Francisco-based venture capital firm specializing in biotechnology and life sciences investments. The firm primarily focuses on early to mid-stage companies, with a strong emphasis on Series A to Series C rounds. Alta Partners typically invests in innovative companies developing cutting-edge therapies, medical devices, and healthcare technologies.

Notable portfolio companies include Vir Biotechnology, eGenesis, and Transcarent. Alta Partners' investment philosophy centers on supporting groundbreaking scientific advancements and disruptive healthcare solutions. The firm leverages its extensive industry network and expertise to provide strategic guidance and operational support to its portfolio companies, helping them navigate the complex landscape of drug development and commercialization.

Alta Partners - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments115
Current Portfolio Count38
Total Portfolio Exits6

Top Investment Stages

Series A28 (27.7%)
Series B27 (26.7%)
Series C20 (19.8%)
Series D16 (15.8%)
Series Unknown10 (9.9%)

Stage Mix

Series A 28%Series B 27%Series C 20%Series D 16%Series Unknown 10%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Harbor Health logo

Harbor Health

Lassen Therapeutics logo

Lassen Therapeutics

MBrace Therapeutics logo

MBrace Therapeutics

Free Market Health logo

Free Market Health

Novome Biotechnologies logo

Novome Biotechnologies

Everside Health logo

Everside Health

DEM Biopharma logo

DEM Biopharma

Kelonia Therapeutics logo

Kelonia Therapeutics

Be Biopharma logo

Be Biopharma

Transcarent logo

Transcarent

ImmuneID logo

ImmuneID

DispatchHealth logo

DispatchHealth

eGenesis logo

eGenesis

Variant Bio logo

Variant Bio

Vir Biotechnology logo

Vir Biotechnology

CuraSen Therapeutics logo

CuraSen Therapeutics

Sutro Biopharma logo

Sutro Biopharma

GenePeeks logo

GenePeeks

aTyr Pharma logo

aTyr Pharma

Kite Pharma logo

Kite Pharma

Agtc logo

Agtc

Cara Therapeutics logo

Cara Therapeutics

Chimerix logo

Chimerix

Pathwork Diagnostics logo

Pathwork Diagnostics

Trevena logo

Trevena

Alta Partners - Similar Investment Firms

Alta Life Sciences logo

Alta Life Sciences

altals.com

Alta Park Capital logo

Alta Park Capital

altaparkcap.com

Altos Ventures logo

Altos Ventures

altos.vc

AltaIR Capital logo

AltaIR Capital

altair.vc

Altitude Life Science Ventures logo

Altitude Life Science Ventures

altitudelsv.com

Pivotal bioVenture Partners logo

Pivotal bioVenture Partners

Foresite Capital logo

Foresite Capital

Atlas Venture logo

Atlas Venture

atlasventure.com

Altos Capital Partners logo

Altos Capital Partners

altos-capital.com

Alta Berkeley Venture Partners logo

Alta Berkeley Venture Partners

Aloft VC logo

Aloft VC

aloftvc.com

Altira Group logo

Altira Group

altiragroup.com

Altman Capital logo

Altman Capital

Mission Bay Capital logo

Mission Bay Capital

Life Science Angels logo

Life Science Angels

Alta Partners - Classification

Also Known As
  • Alta Partners Management Corp
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end